English | Español
John Breslin | Feb 24, 2016

Partisan-based positions threaten U.S. scientific leadership, ITIF report indicates
Jamie Barrand | Feb 24, 2016

Supplemental New Drug Application submitted to FDA for prostate cancer therapy
Jamie Barrand | Feb 24, 2016

Trial underway for new dosage of HIV-1 therapy
Jamie Barrand | Feb 24, 2016

Romosozumab decreases spinal fracture risk in postmenopausal women, study indicates
Jamie Barrand | Feb 24, 2016

Pricewaterhouse Cooper awards million-dollar grant to Easter Seals Dixon Center
Jamie Barrand | Feb 24, 2016

GSK, Save the Children announce Healthcare Innovation Award winners
Jamie Barrand | Feb 23, 2016

Hotopp receives NIH award for lateral gene transfer research
Jamie Barrand | Feb 23, 2016

European Commission approves marketing for AstraZeneca's new gout treatment

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’